Framework Agreement for the supply of pralidoxime chloride injection
The value below is a framework or dynamic market ceiling: the maximum
that could be spent across all call-offs, not the value of a single contract.
Aggregate figures on this site exclude these to avoid double counting.
key details
| Status | complete |
|---|---|
| Category (CPV) | 33600000 |
| Region | Scotland, Wales, Northern Ireland |
| Deadline | 19 Aug 2019 |
| Contract start | 1 Apr 2020 |
| Contract end | 31 Mar 2022 |
| Procedure | selective |
| SME suitable | No |
| OCID | ocds-b5fd17-efabb6e4-8e68-42ab-8440-7b558df6223c |
Award
| Supplier | Value | Date | Status |
|---|---|---|---|
| Baxter Healthcare Ltd | £0 | 1 Oct 2019 | active |
description
Framework Agreement has been established for the supply of pralidoxime chloride for injection, to place call-offorders as and when required during the life of the Framework Agreement.
The duration of the Framework Agreement is 2 years with an option to extend for up to an additional 2 years.
documents
- https://www.contractsfinder.service.gov.uk/Notice/a933cd3f-44c1-4dd7-ad43-059fc01d0063 , tenderNotice
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/11fcbe00-be84-4cd4-a415-938bdd11af15 , tenderNotice
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/47130f30-3046-4613-abbe-4b6cbc90efb2 , tenderNotice
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/81f7cd54-de7a-4a11-8ad7-50da7b21716b , tenderNotice
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/cb92bd1b-3384-4b92-b0ba-664d68979b0a , tenderNotice
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/e6baffc0-50a6-47b1-9b82-7e559fe82ae0 , tenderNotice
Documents are linked, not mirrored. They are served by the publishing authority and may require registration.
notice history
1 notice published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 10 Oct 2019 | Award (award) | · | 2a9178ab-03e8-44c6-bfb9-73af5a3577e7-318795 |
more from Department of Health and Social Care
- DHSC: Fin: Interim Senior Financial Accountant · £94,250 · 29 Jul 2026
- DHSC: Fin: Interim Financial Accountant · £66,400 · 29 Jul 2026
- DHSC Sinogo claim legal support · £100,000 · 22 Jul 2026
- National Institute for Health and Care Research (NIHR) pre-action letter advice · £80,000 · 22 Jul 2026
- DHSC: ASC: Waves 3 – 5 of the Adult Social Care Workforce Employee Survey · 15 Jul 2026
- Hugh's Report - MH Impact of Life-Threatening Child Illness on Families 2026 · 26 Jun 2026
- Library Mgmt and Enquiry System, E-Archive · £22,578 · 22 Jun 2026
- DHSC: Leeds Maternity Review legal services · £432,000 · 22 Jun 2026
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.